Analyst Reco. Merck & Co., Inc.

Equities

MRK

US58933Y1055

Market Closed - Nyse Other stock markets 04:00:02 2024-05-13 pm EDT			5-day change	1st Jan Change
129.3 ^USD	-0.59%		+1.35%	+18.59%

May. 13	Merck: phase 3 trial in melanoma halted	CF
May. 13	Merck Ends Co-Formulation Arm of Keytruda High-Risk Melanoma Study	DJ

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Redburn Atlantic Adjusts Price Target on Merck to $148 From $142	May. 01	MT
Wolfe Research Adjusts Price Target on Merck & Company to $151 From $141	Apr. 26	MT
Morgan Stanley Adjusts Merck & Co.'s Price Target to $132 From $128	Apr. 26	MT
Guggenheim Adjusts Price Target on Merck to $146 From $144	Apr. 26	MT
Wells Fargo Adjusts Price Target on Merck & Company to $140 From $135	Apr. 26	MT
Deutsche Bank Adjusts Price Target on Merck & Company to $140 From $135	Apr. 26	MT
JPMorgan Chase Adjusts Price Target on Merck to $145 From $140	Apr. 26	MT
Goldman Sachs Raises Price Target on Merck & Company to $144 From $139	Apr. 26	MT
Leerink Partners Raises Price Target on Merck & Company to $136 From $132	Apr. 26	MT
Truist Lifts Price Target on Merck to $143 From $142, Keeps Buy Rating	Apr. 26	MT
Jefferies Adjusts Merck & Company Price Target to $150 From $145	Apr. 26	MT
Cantor Fitzgerald Adjusts Merck & Co.' Price Target to $155 From $135, Keeps Overweight Rating	Apr. 25	MT
BMO Capital Adjusts Price Target on Merck & Company to $148 From $132	Apr. 19	MT
Leerink Partners Raises Merck's Price Target to $134 From $129	Apr. 19	MT
Zacks Adjusts Price Target on Merck & Company to $132 From $128	Apr. 15	MT
Berenberg Raises Price Target on Merck & Company to $143 From $140, Maintains Buy Rating	Apr. 08	MT
Truist Securities Raises Merck Price Target to $142 From $139, Maintains Buy Rating	Mar. 27	MT
Wells Fargo Raises Price Target on Merck to $135 From $130, Maintains Equal-Weight Rating	Mar. 27	MT
Societe Generale Downgrades Merck to Sell From Hold, Raises Price Target to $104 From $103	Mar. 11	MT
ANALYST RECOMMENDATIONS : Doordash, Merck, Eli Lilly, Walt Disney, Pearson...	Mar. 04

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Merck & Co., Inc.

Equities

MRK

US58933Y1055

Analyst Reco.

Filters